ArticleInternational journal of oral science2026

Antisense oligonucleotide targeting TARDBP-EGFR splicing axis inhibits progression of oral squamous cell carcinoma through ABCA1-regulated cholesterol efflux.

Nan Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.